Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details)

v3.23.3
Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Earnings Per Share    
Net earnings, including noncontrolling interest $ 50,993 $ 89,734
Less net earnings (loss) attributable to noncontrolling interest   179
Net earnings attributable to Bio-Techne 50,993 89,555
Income allocated to participating securities (8) (26)
Income available to common shareholders $ 50,985 $ 89,529
Weighted-average shares outstanding - basic (in shares) 158,130 156,929
Earnings per share - basic (in shares) $ 0.32 $ 0.57
Income available to common shareholders $ 50,985 $ 89,529
Dilutive effect of stock options and restricted stock units (in shares) 3,810 5,243
Weighted-average common shares outstanding - diluted (in shares) 161,940 162,172
Earnings per share - diluted (in shares) $ 0.31 $ 0.55